Please try another search
For the three months ended 31 March 2018, AveXis Inc revenues was not reported. Net loss increased from $29.7M to $222.1M. Higher net loss reflects Research and development - Balancing increase from $18.3M to $192.7M (expense), General and administrative - Balancing increase from $6.9M to $17.5M (expense), Stock-based Compensation in R&D increase from $2M to $7M (expense).
Period Ending: | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 |
---|---|---|---|---|
Total Revenue | 0 | 0 | 0 | 0 |
Gross Profit | ||||
Operating Income | -222.46 | -82.52 | -49.52 | -58.36 |
Net Income | -222.1 | -81.67 | -48.64 | -58.03 |
Period Ending: | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 |
---|---|---|---|---|
Total Assets | 391.58 | 432.06 | 469.31 | |
Total Liabilities | 58.84 | 28.01 | 27.88 | |
Total Equity | 332.74 | 404.05 | 441.42 |
Period Ending: | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 |
---|---|---|---|---|
Period Length: | 0 Months | 12 Months | 9 Months | 6 Months |
Cash From Operating Activities | -157.38 | -113.56 | -76.35 | |
Cash From Investing Activities | -32.05 | -23.36 | -16.76 | |
Cash From Financing Activities | 273.12 | 270.71 | 270.3 | |
Net Change in Cash | 83.69 | 133.78 | 177.19 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review